Results 21 to 30 of about 222 (120)
PS1481 PLATELET REACTIVITY AND RESPONSE TO ANTIPLATELET DRUGS IN THROMBOCYTOPENIA AND THROMBOCYTOSIS
HemaSphere, Volume 3, Issue S1, Page 682-683, June 2019., 2019 Background: Antiplatelet therapy for coronary artery disease (CAD) in patients with quantitative platelet disorders is still a matter of debate. Possible changes in platelet reactivity may also influence the response to these treatment. But platelet response to the antiplatelet drugs is not routinely examined, and the relevant evidence is scarce. Aims:
W. Kuliczkowski +7 more
wiley +1 more source
CLINICAL MASKS OF BONE SARCOMAS IN CHILDREN: SIX CLINICAL CASES
Вопросы современной педиатрии, 2018 Background. Solid tumors in children are one of the most common childhood malignancy, second only to hemoblastosis. Among solid tumours, about 5% are bone sarcomas: osteosarcoma (3%) and Ewing's sarcoma (2%).
Maxim Yu. Rykov
doaj +1 more source
HemaSphere, Volume 3, Issue S1, Page 683, June 2019., 2019 Background: ITP patients have an increased risk of thrombosis, and TPO‐RA‐treatment may further increase this risk. Studies have shown that procoagulant microvesicles (MVs), soluble P‐selectin and plasminogen activator inhibitor‐1 (PAI‐1) are increased in ITP patients and may contribute to the increased thrombotic risk.
L. Garabet +10 more
wiley +1 more source
Хронический остеомиелит челюсти как проявление онкогематологической патологии в пожилом возрасте [PDF]
, 2019 Рассмотрен клинический случай онкогематологического заболевания в пожилом ...
Журавлев, Ю. И. +4 more
core +2 more sources
Immunomodulating effects of antitumor drugs Bruton tyrosine kinase inhibitors and the possibility of their use in allergic and infectious diseases [PDF]
, 2023 Bruton's tyrosine kinase (BTK) inhibitors represent a class of drugs that have demonstrated their efficacy and safety in patients with chronic lymphocytic leukemia and non-Hodgkin's lymphomas who were considered refractory to any previously used type of ...
M. A. Mikhalyova +4 more
core +2 more sources
EHA2021 Virtual Congress Abstract Book
, 2021 HemaSphere, Volume 5, Issue S2, June 2021.
wiley +1 more source
PS1483 IMPACT OF NEXT GENERATION SEQUENCING ON DIAGNOSIS OF INHERITED THROMBOCYTOPENIAS
HemaSphere, Volume 3, Issue S1, Page 683, June 2019., 2019 Background: Differential diagnosis of isolated chronic thrombocytopenia is often challenging and covers a wide range of disorders, including immune thrombocytopenia (ITP), inherited platelet functional disorders (IPFD), onset of bone marrow failure and secondary thrombocytopenias.
D. Fedorova +7 more
wiley +1 more source
MALIGNANT NEOPLASMS IN CHILDREN: CLINICAL MANIFESTATIONS AND DIAGNOSIS
Вопросы современной педиатрии, 2017 Treatment efficacy for children with cancer depends on the diagnosis timeliness since the earlier expert care has been started, the higher likelihood there is to achieve remission.
Maxim Yu. Rykov +2 more
doaj +1 more source
HemaSphere, Volume 3, Issue S1, Page 805-806, June 2019., 2019 Background: Epigenetic changes are encountered in acute myeloid leukemia (AML) and are thought to contribute to leukemogenesis. Decreased histone acetylation was frequently found in AML, especially in high‐risk cytogenetics, higher age, secondary or relapsed/refractory AML. HDAC inhibitors have been found to be effective in AML.
W. Yao, J. Tong, H. Liu, Z. Sun
wiley +1 more source
MALIGNANT NEOPLASMS IN CHILDREN POPULATION OF TOMSK REGION
Вопросы современной педиатрии, 2013 Worldwide prevalence of oncology diseases among children under 15 years old is relatively low — 8,4 on 100 000 of children population (), but they are one of the most common causes of mortality in this population.
L. F. Pisareva +5 more
doaj +1 more source